Antares Pharma (AIS)
Antares Pharma Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 30.19M | 31.37M | 26.12M | 33.33M | 13.07M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | 1.409M | 2.535M | 1.987M | 1.301M | 1.607M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Inventory | 1.313M | 0.8918M | 0.3515M | 0.4222M | 0.335M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Prepaid Expenses | 0.2532M | 0.3572M | 0.255M | 0.2176M | 0.2547M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Assets | 34.81M | 36.27M | 29.91M | 36.35M | 15.92M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accumulated Depreciation | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Property, Plant & Equipment | 0.7707M | 0.5917M | 0.4941M | 0.4633M | 0.4067M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | 3.006M | 3.027M | 6.048M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Goodwill & Intangibles | 2.072M | 2.048M | 2.017M | 2.039M | 1.934M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Long Term Assets | 0.068M | 0.0312M | 0.0314M | 0.0318M | 0.0313M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Assets | 5.917M | 5.698M | 8.590M | 2.534M | 2.372M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 40.73M | 41.96M | 38.50M | 38.88M | 18.29M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accounts Payable | 2.927M | 2.139M | 1.829M | 2.285M | 1.973M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | 1.737M | 2.225M | 1.653M | 1.141M | 0.6732M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Revenues | 3.177M | 5.644M | 3.279M | 3.250M | 3.841M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Liabilities | 7.841M | 10.01M | 6.761M | 6.677M | 6.487M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Long Term Liabilities | 0.791M | 0.8104M | 0.8398M | 0.8692M | 1.014M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 8.632M | 10.82M | 7.601M | 7.546M | 7.501M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 103.96M | 103.55M | 103.51M | 103.06M | 87.80M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Preferred Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Common Stock, Net | 1.040M | 1.036M | 1.035M | 1.031M | 0.878M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Additional Paid-in Capital | 173.13M | 172.07M | 171.63M | 170.75M | 148.83M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Retained Earnings | -141.44M | -141.36M | -141.21M | -139.91M | -138.35M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Treasury Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Shareholder's Equity | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 32.09M | 31.14M | 30.89M | 31.33M | 10.79M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 40.73M | 41.96M | 38.50M | 38.88M | 18.29M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |